April 01, 2026 12:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Unsubstantial allegations’: Calcutta HC dismisses plea on ECI’s officer transfers in Bengal | Tennis icon Leander Paes joins BJP ahead of Bengal polls | 8 killed, several injured in crowd crush at Bihar temple in Nalanda | Trump signals exit from Iran war even as Strait of Hormuz remains shut: Report | Mystery death in Pakistan: JeM chief Masood Azhar’s brother found dead | Trump shares Iran blasts video after fresh ‘blow up’ threat | Sensex plunges 1,600 pts, Nifty below 22,400 as oil price spike rattles markets | Nitish Kumar quits as Bihar CM after Rajya Sabha entry | Modi says govt taking steps to shield Indians from impact of Middle East crisis | Bengal polls a ‘fight for liberation from fear’, says Amit Shah as he unveils TMC chargesheet
Omicron
UNI

India registers 7,145 new COVID-19 cases in past 24 hours amid Omicron spread scare

| @indiablooms | Dec 18, 2021, at 03:11 pm

New Delhi: India, a nation which is witnessing a spike in Omicron cases, registered 7,145 new COVID-19 cases in the past 24 hours, as per data released by the Ministry of Health on Saturday.

During the same period, 391 people died due to the disease.

India's Active caseload currently stands at 84,565, lowest in 569 days.

Active cases account for less than 1 percent of total cases.

It currently stands at 0.24 percent.

8,706 recoveries were recovered in the last 24 hours.

Recovery Rate currently stands at 98.38 percent.

The World Health Organization (WHO) on Friday announced that  it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.

"Today, the World Health Organization issued and emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus," the WHO said in a statement.

The vaccine, named CovovaxTM, is produced by the Serum Institute of India (SII) under license from Novavax and is part of the COVAX facility portfolio.

The vaccine approval is "a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.